Analysts Offer Predictions for DNLI FY2027 Earnings
Investment analysts at Zacks Research issued their FY2027 earnings per share estimates for shares of Denali Therapeutics in a ...
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.9% After Analyst Downgrade
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) were down 8.9% during trading on Monday after Bank of America lowered their price target on the stock from $30.00 to $28.00. Bank of ...